KPKristin Palmsten

Kristin Palmsten

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kristin Palmsten has a total of 115 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Intellectual and developmental disability diagnoses in California delivery records and adverse maternal outcomes

    by Catherine Psaras, Rita H. Ryu, Rebecca J. Baer, Kristin Palmsten, Jerasimos Ballas, Jaime Barea, Jeanne Townsend, Timothy Wen, Talya Tasini, Gretchen Bandoli

    Background: Women with intellectual and developmental disability (IDD) are a population whose maternal health outcomes remain poorly documented. We estimated associations between maternal IDD diagnosis in California birth records and adverse maternal outcomes, and assessed whether prenatal clinical characteristics mediate these relationships. Methods: This retrospective population‐based cohort study included all deliveries ≥22 weeks’ gestation in California between 2007 and 2021, using birth and fetal death certificates linked to inpatient and emergency department records. Outcomes included severe maternal morbidity (SMM), cesarean delivery, preeclampsia, and maternal hospital admission in the year following delivery. We calculated adjusted risk ratios (aRRs) matched on maternal age and year of delivery. We examined IDD as a single category and by subtype: autism spectrum disorder (ASD), cerebral palsy (CP), intellectual disability (ID), chromosomal differences, and other IDDs. Mediators included tobacco use, pre‐existing hypertension, pre‐existing diabetes, preeclampsia, prepregnancy body mass index, epilepsy, depression/anxiety, bipolar disorder or schizophrenia, and adequate prenatal care. Results: Among 6,435,742 singleton births, 4492 mothers (0.07%) had an IDD diagnosis. Women with IDD faced elevated risks across all adverse outcomes compared to those without: SMM—aRR: 2.77, 95% CI: 2.40, 3.19; cesarean delivery—aRR: 1.44, 95% CI: 1.39, 1.50; preeclampsia—aRR: 2.52, 95% CI: 2.30, 2.77; and hospital admission within 1 year of delivery—aRR: 4.64, 95% CI: 4.26, 5.05. While risk was elevated for all subtypes across all outcomes, ID tended to confer the highest risk. In the mediation analysis, hypertensive disorders and mental health conditions were the strongest individual mediators. In a joint mediation analysis, select perinatal characteristics explained half of the excess risk of cesarean delivery (autism), preeclampsia (autism), hospital admission (ID), and SMM (ID). Conclusions: Women with IDD documented in California birth records face substantially elevated risks of adverse maternal outcomes, with the largest disparities in hospital admission in the year following delivery. Hypertensive disorders, depression, and anxiety were the strongest potential mediators of those analyzed, and should be further evaluated as intervention targets. Given our reliance on inpatient diagnostic codes, findings may generalize most reliably to women with IDD with the highest support needs.

  • Provider Perspectives to Inform a Patient‐Facing Decision Aid on Oral Corticosteroid Use During Pregnancy and Evaluation of the Aid

    by Kristin Palmsten, Elisabeth A. Seburg, Jeanette Y. Ziegenfuss, Gabriela Vazquez‐Benitez, Meghan M. JaKa, Christina D. Chambers, Lyndsay A. Avalos, Elyse O. Kharbanda

    Purpose: We previously identified patient need for a decision aid on oral corticosteroid (OCS) use during pregnancy that could be used to support discussions between providers and patients. In the current study, we aimed to identify healthcare provider needs for a decision aid on OCS use during pregnancy and then evaluated the usefulness of the decision aid that we developed. Methods: Before developing a decision aid on OCS use during pregnancy, we conducted semi‐structured interviews with providers from one health system to understand needs for an aid for counseling patients about OCS use during pregnancy. To assess the usefulness of the decision aid that we developed, providers reviewed the decision aid and responded to survey questions. Also, the survey assessed provider knowledge regarding counseling on OCS use during pregnancy before and after reviewing the aid (knowledge scores range 0–15). Results: In interviews, all providers ( n = 13) reported that a patient‐facing decision aid would be useful when discussing OCS use during pregnancy because it would give information to patients and providers, and it would facilitate decision making. Among the providers who participated in the survey ( n = 68), two‐thirds reported after reviewing the aid that they would usually or always use the decision aid in conversations about OCS treatment during pregnancy. All survey participants reported that they would recommend the decision aid to colleagues. Overall, providers' median knowledge score improved by 1 (IQ range 3) after reviewing the decision aid ( p < 0.01). Conclusions: We established the usefulness of a decision aid on OCS use during pregnancy for providers.

  • Open Access

    Severe maternal morbidity and hypertensive disorders of pregnancy among women with intellectual disabilities: Identifying potential intervention targets

    by Rita Ryu, Catherine Psaras, Rebecca J. Baer, Kristin Palmsten, Jeanne Townsend, Jaime J. Barea, Jerasimos Ballas, Gretchen Bandoli


  • Comparison of Lactation Information from Electronic Health Records with Survey Data Across Five US Health Systems

    by Gregory P. Jansen, Elisabeth M. Seburg, Gabriela Vazquez-Benitez, Kirsten Ehresmann, Hibo H. Mohamed, Lyndsay A. Avalos, Sonya Negriff, Amy M. Loree, Connor K. Howick, Yihe G. Daida, et al.

    Background: Data on lactation status for research are often collected through surveys. Information on human milk feeding collected at routine healthcare visits and stored in electronic health records (EHR) is an emerging source of data for lactation research. We compared information on milk feeding obtained from structured EHR fields with survey data. Methods: We included participants from five US healthcare systems in the Managing Our Mood survey. Individuals had a live birth (March 2022–October 2023), depression diagnosis during pregnancy, and ≥1 record of human milk feeding information in their or their infant’s EHR. We compared information from EHR data up to ten months after delivery with survey data collected 3–4 months after delivery as the reference. We assessed agreement on lactation status (human milk feeding ever and at survey) using percent agreement, Cohen’s kappa, sensitivity, specificity, positive predictive value, and negative predictive value overall and by characteristics. Results: According to survey data, the prevalence of human milk feeding ever was 93.2% and was 73.0% at the time of survey among 281 eligible individuals. Agreement between data sources for ever and for human milk feeding at the survey was ≥92% with kappas ≥0.77. EHR and survey data agreed on human milk feeding ever for 97.3% (95% confidence interval: 94.6%, 98.7%) and on human milk feeding at the time of the survey for 98.0% (95% confidence interval: 95.1%, 99.2%) of those who reported yes to these practices on the survey. These measurements were lower among individuals with fewer records. Conclusions: There was substantial agreement on lactation status between EHR and survey data. These findings suggest that lactation information from structured EHR may be used for epidemiologic research.


  • Comparison of Linked EHR ‐Pharmacy Data and Administrative Claims Data: Medication Fills During Pregnancy

    by Gregory P. Jansen, Gabriela Vazquez‐Benitez, Kirsten Ehresmann, Elisabeth M. Seburg, Margaret B. Nolan, Kristin Palmsten

    Purpose: Electronic health records (EHR) offer clinical details not available in claims data, which are typically used for studies of medications during pregnancy. Historically, medication prescriptions rather than fills have been documented in EHR. However, linked EHR–pharmacy databases incorporate medication fill information and could be used for perinatal medication safety studies. Methods: This study compared fills of common medications during pregnancy using linked EHR–pharmacy data and claims data from a healthcare system in Minnesota, USA among patients with a delivery (2017–2021) and insurance coverage. We assessed prevalence differences and agreement using percent agreement and Cohen's κ for 27 medications. The percent of individuals with a fill according to one data source within ±1 day of their first medication fill in the other data source was assessed. Results: Among the 12 440 pregnancies included, there was a slightly higher prevalence of all medications of interest in linked EHR–pharmacy versus claims data. The prevalence difference was 1.5% for the medication with the largest difference. Percent agreement was > 97% for all medications; κ ≥ 0.870. The percentage of individuals with a fill according to linked EHR–pharmacy data within ±1 day of their first medication fill in claims data was higher than the reverse (claims data fill within ±1 day of linked EHR–pharmacy data fill) for all medications. Conclusions: Although agreement between sources was high, linked EHR–pharmacy data identified slightly more individuals with medication fills during pregnancy than claims data. Linked EHR–pharmacy data may provide comprehensive medication fill data for studying medications during pregnancy. Plain Language Summary: Many studies of medication safety during pregnancy rely on health insurance claims data. These data may not have important details about patient health. EHRs provide more complete clinical information, and they have been linked with pharmacy data to add prescription fill records. We assessed how well medication fill records agreed between linked EHR–pharmacy data and claims data for 27 commonly used medications in pregnancy. Using data from a Minnesota healthcare system, we analyzed records from 12 440 pregnancies occurring from 2017 to 2021 with health insurance benefits, prenatal care, and postnatal care. We compared the frequency of medication fills in each data source and assessed agreement using statistical methods. The datasets usually agreed on whether a patient filled a particular medication during pregnancy. However, linked EHR–pharmacy data identified slightly more individuals with medication fills during pregnancy than claims data. This suggests that linked EHR‐pharmacy data may be useful for perinatal medication safety research.


  • Linkage of Electronic Health Record Data Across Two Healthcare Systems for Perinatal Health Research: A Privacy‐Preserving Approach

    by Kirsten Ehresmann, Claire Smith, Gabriela Vazquez‐Benitez, Elisabeth M. Seburg, Terese A. DeFor, Asha Farah, Abbey Sidebottom, Kristin Palmsten

    Background: In the United States, birthing parent‐infant dyads may receive care from multiple healthcare systems. Linkage of an individual's electronic health records (EHR) across healthcare systems, in addition to birthing parent‐infant linkage, may be necessary to obtain appropriate clinical data for perinatal health research. Objectives: To develop a privacy‐preserving process to link the health records of patients shared by two health systems for a perinatal health study, and to assess data enhancements associated with the linkage. Methods: We included pregnant patients who received care from at least one of two healthcare systems based in Minnesota, USA and their infants born between December 2020 and September 2022 who had at least one well visit. We identified infants from one health system with birthing parents who potentially received care in the second health system based on the infant's delivery hospital. We implemented a one‐way matching process using an algorithm to generate unique hash values for each record at each health system. Specifically, we used four hash ID rules based on six identifiers available in the EHR at both sites plus a consistent salt. Results: One health system identified 3524 infants with birthing parents who potentially received care in the second system. The second system identified 39,321 infants delivered at the hospitals of interest during the study period. The algorithm matched 3406 (96.7%) infant records. After applying the study eligibility criteria, the birthing‐parent records gained through hash matching increased the study population by 7.2% from 8100 to 8686. Overall, 13.6% of the study population had data from the second health system. Some demographic and pregnancy characteristics differed from those with data from the first system only. Conclusions: The hash matching approach can increase study size, patient diversity, and data completeness in a privacy‐preserving manner for perinatal health studies among patients that use multiple healthcare systems.


  • Open Access

    Opportunities and Challenges to Leveraging Real-World Data for Post-Market Safety Studies in Pregnancy and Lactation

    by Carla Rodriguez-Watson, Kaylan Ware, Joy C. Eckert, Leonardo Roque Pereira, Emily Bratton, Kristin Palmsten

    A document by Carla Rodriguez-Watson. Click on the document to view its contents.

  • Characterisation and validation of lactation information from structured electronic health records for use in pharmacoepidemiological studies

    by Hibo H. Mohamed, Kirsten Ehresmann, Elisabeth M. Seburg, Gabriela Vazquez‐Benitez, Ellen W. Demerath, David A. Fields, Kimberly K. Vesco, Elyse O. Kharbanda, Kristin Palmsten

    Background: Breastfeeding information stored within electronic health records (EHR) has recently been used for pharmacoepidemiological research, however the data are primarily collected for clinical care.Objectives: To characterise breastfeeding information recorded in structured fields in EHR during infant and postpartum health care visits, and to assess the validity of lactation status based on EHR data versus maternal report at research study visits.Methods: We assessed breastfeeding information recorded in structured fields in EHR from one health system for a subset of 211 patients who were also enrolled in a study on breast milk composition between 2014 and 2017 that required participants to exclusively breastfeed their infants until at least 1 month of age. We assessed the frequency of breastfeeding information in EHR during the first 12 months of age and compared lactation status based on EHR with maternal report at 1 and 6‐month study visits (reference standard).Results: The median number of breastfeeding records in the EHR per infant was six (interquartile range 3) with most observations clustering in the first few weeks of life and around well‐infant visits. At the 6‐month study visit, 93.8% of participants were breastfeeding and 80.1% were exclusively breastfeeding according to maternal report. Sensitivity of EHR data for identifying ever breastfeeding was at or near 100%, and sensitivity for identifying ever exclusive breastfeeding was 98.0% (95% CI: 95.0%, 99.2%). Sensitivities were 97.3% (95% CI: 93.9%, 98.9%) for identifying any breastfeeding and 94.4% (95% CI: 89.7%, 97.0%) for exclusive breastfeeding, and positive predictive values were 99.5% (95% CI: 97.0%, 99.9%) for any breastfeeding and 95.0% (95% CI: 90.4%, 97.4%) for exclusive breastfeeding.Conclusions: Breastfeeding information in structured EHR fields have the potential to accurately classify lactation status. The validity of these data should be assessed in populations with a lower breastfeeding prevalence.


  • The most common medications dispensed to lactating persons: An electronic health record‐based approach

    by Kristin Palmsten, Gabriela Vazquez‐Benitez, Meghan M. JaKa, Gretchen Bandoli, Katherine A. Ahrens, Elyse O. Kharbanda

    Purpose: Using a novel, electronic health record (EHR)‐based approach, to estimate the prevalence of prescription medication use at 2, 4, and 6 months postpartum among lactating individuals.Methods: We utilized automated EHR data from a US health system that records infant feeding information at well‐child visits. We linked mothers who received prenatal care to their infants born May 2018–June 2019, and we required infants to have ≥1 well‐child visit between 31 and 90 days of life (i.e., 2‐month well‐child visit with a ±1 month window). Mothers were classified as lactating at the 2‐month well‐child visit if their infant received breast milk at the 2‐month well‐child visit. For subsequent well‐child visits at 4 and 6 months, mothers were considered lactating if their infant was still receiving breast milk.Results: We identified 6013 mothers meeting inclusion criteria, and 4158 (69.2%) were classified as lactating at the 2‐month well‐child visit. Among those classified as lactating, the most common medication classes dispensed around the 2‐month well‐child visit were oral progestin contraceptives (19.1%), selective serotonin reuptake inhibitors (8.8%), first generation cephalosporins (4.3%), thyroid hormones (3.5%), nonsteroidal anti‐inflammatory agents (3.4%), penicillinase‐resistant penicillins (3.1%), topical corticosteroids (2.9%), and oral imidazole‐related antifungals (2.0%). The most common medication classes were similar around the 4 and 6‐month well‐child visits although prevalence estimates were often lower.Conclusions: Progestin‐only contraceptives, antidepressants, and antibiotics were the most dispensed medications among lactating mothers. With routine collection of breastfeeding information, mother‐infant linked EHR data may overcome limitations in previous studies of medication utilization during lactation. These data should be considered for studies of medication safety during lactation given the need for human safety data.


  • Open Access

    Association of Prenatal Depression With New Cardiovascular Disease Within 24 Months Postpartum

    by Christina M. Ackerman‐Banks, Heather S. Lipkind, Kristin Palmsten, Mariah Pfeiffer, Catherine Gelsinger, Katherine A. Ahrens

    Background: Although depression is well established as an independent risk factor for cardiovascular disease (CVD) in the nonpregnant population, this association has largely not been investigated in pregnant populations. We aimed to estimate the cumulative risk of new CVD in the first 24 months postpartum among pregnant individuals diagnosed with prenatal depression compared with patients without depression diagnosed during pregnancy. Methods and Results: Our longitudinal population‐based study included pregnant individuals with deliveries during 2007 to 2019 in the Maine Health Data Organization's All Payer Claims Data. We excluded those with prepregnancy CVD, multifetal gestations, or no continuous health insurance during pregnancy. Prenatal depression and CVD (heart failure, ischemic heart disease, arrhythmia/cardiac arrest, cardiomyopathy, cerebrovascular disease, and chronic hypertension) were identified by International Classification of Diseases, Ninth Revision ( ICD‐9 )/ International Classification of Diseases, Tenth Revision ( ICD‐10 ) codes. Cox models were used to estimate hazard ratios (HRs), adjusting for potential confounding factors. Analyses were stratified by hypertensive disorder of pregnancy. A total of 119 422 pregnancies were examined. Pregnant individuals with prenatal depression had an increased risk of ischemic heart disease, arrhythmia/cardiac arrest, cardiomyopathy, and new hypertension (adjusted HR [aHR], 1.83 [95% CI, 1.20–2.80], aHR, 1.60 [95% CI, 1.10–2.31], aHR, 1.61 [95% CI, 1.15–2.24], and aHR, 1.32 [95% CI, 1.17–1.50], respectively). When the analyses were stratified by co‐occurring hypertensive disorders of pregnancy, several of these associations persisted. Conclusions: The cumulative risk of a new CVD diagnosis postpartum was elevated among individuals with prenatal depression and persists even in the absence of co‐occurring hypertensive disorders of pregnancy. Further research to determine the causal pathway can inform postpartum CVD preventive measures.